16/08/2024
The 24th BioInnovation Seminar (24023, online) [Theme: Open Insulin Project]
1. Date and time
○ Date and time: 09:00-11:00(GMT+9) on Friday, August 23, 2024
○ Location: Online (Zoom)
2. Seminar overview (seminar will be held in English, no separate interpretation)
OPEN INSULIN Project:
The Open Insulin Project is a project of OPEN ISULIN FOUNDATION, a non-profit organization that supports the supply and demand of insulin drugs of the same quality as commercialized insulin drugs in each country and local government.
The Open Insulin Foundation aims to support the self-supply of essential survival treatments with the same quality as commercialized products, starting with insulin drugs.
The Open Insulin Foundation, founded by Dr. Anthony DiFranco in 2015, aims to provide easy access to more diabetics by eliminating the unnecessarily high price of insulin drugs and resolving patent and production problems of insulin sanctions to establish a state-level production facility in the United States.
Founder Dr. Anthony di Franco and Dr. Roger Erickson, who is consulting on the production of insulin drugs, would like to introduce the current and future direction of the Open Insulin Project as a speaker.
Chairperson: Julie Lee(CEO of Medclaris)
09:00 – 09:45: Open Insulin Project – Lessons and Prospects in Organizing Open Medicine
(Dr. Anthony di Franco, Founder of Open Insulin Project)
[Main content]
Anthony will speak about the history, context, and distinctive strategy of Open Insulin, the broader incentives and constraints in medicine, and implications for curing diabetes and progress on other so far intractable medical issues.
[Speaker Instruction]
Anthony Di Franco is founder and president of the Open Insulin Foundation, an effort to make local scale production of insulin and other essential biologic medicines on an open source basis feasible. A type 1 diabetic himself, he maintains an active interest in developing a gene therapy for diabetes, which he is in the process of pursuing in a new venture. Anthony is also researching purely declarative probabilistic-relational languages with applications in verified computing, computer security, and agent-based software systems in view. Previously, he researched numerical computation, purely declarative probabilistic-relational programming languages, and other topics at the intersections of programming languages and machine learning in the PhD program at UC Davis. Anthony holds a BS in Physics and a BS in Computer Science and Mathematics from Yale University, where he studied control theory, statistics and information theory, and neural networks.
09:45-10:00: Q&A
10:00 - 10:45: Realizing Open Insulin through Sustainable Production Systems (Dr. Roger Erickson, Founder of Interbiome Partners)
Interbiome is working to enable universal access to reliable, clinical-dosing of the Open Insulin product, by establishing a worldwide franchise system providing STABLE AND DISTRIBUTED MANUFACTURING PROCESSES, for regional production of any and all needed pharmaceutical products. In addition to OpenInsulin, this Public Utility Standards approach to will manufacture products that regional populations need, but private investors will not make (Dr. Roger Erickson, Founder of Interbiome Partners).
[Main content]
Interbiome is currently working with the OpenInsulin Foundation to finalize Process Development and establish a stable Tech Transfer platform and protocol. In this way the foundations developed by the Open Insulin Project can become available via documented Tech Transfer through any Interbiome franchise worldwide.
[Speaker Instruction]
Roger G. Erickson, PhD.
Interbiome Partners, LLC; Maryland, USA
Dr. Erickson is the founder of a holding company created to provide Stable, Distributed Drug Manufacturing franchises worldwide.
Dr. Erickson began his career in neurophysiology research in Portland, Oregon, received his PhD from SUNY/Buffalo, held post-doctoral fellowships in Tubingen, Boston and Connecticut, and was a Sr. Staff Fellow at the NIMH in Maryland. He has since enlarged his interests from neural systems to community and Population Health systems and has pioneered use of Contract Drug Manufacturing franchises as a vehicle for adaptive evolution of Population Health Supply Chains. Dr. Erickson has launched the Interbiome platform as a method for introducing a more distributed, Public Utility approach to providing many needed but missing, delayed and/or abandoned pharmaceutical products which profit-maximizing investors will not provide. The Interbiome approach bridges short-term profit-seeking and long-term coordination, by building and sustaining an affordable, distributed Reserve Capacity of both Human and Physical Capital.
Personal Background:
Roger Erickson grew up in Portland, Oregon, received a BA-Biology from Reed College, and a PhD-Physiology from SUNY-Buffalo. His research experiences include fellowships at the Alexander von Humboldt Stiftung in Germany, MIT Brain & Cognitive Sciences, Yale Medical School, and the National Institute of Mental Health.
10:45-11:00: Q&A
3. Participation fee: Free
4. Host: Chungbuk BioHealth Industry Innovation Center, Precision Medical Device Business Group (Transportation University)
5. Organized by: Bestian Foundation, Chungbuk Institute of Bio-Industry Convergence
6. Sponsor: Osong BioHealth Council (OBHA)
6. Persons eligible for attendance: persons interested in the bio-industry, including persons in the bio-industry of Chungbuk, etc
7. How to apply: Apply at the link below
https://forms.gle/L2pyDRYSTAFTKhh4A
- 문의 : (+82-70-7603-8068, global_bestian@naver.com)
8. Closing: August 16 (Fri) 24:00 (1st closing)
The 24th BioInnovation Seminar (24023, online) [Theme: Open Insulin Project] 1. Date and time ○ Date and time: 09:00-11:00(GMT+9) on Friday, August 23, 2024 ○ Location: Online (Zoom) 2. Seminar overview (seminar will be held in English, no separate interpretation) OPEN INSULIN Project: The Open...
![The 24th BioInnovation Seminar (24023, online) [Theme: Open Insulin Project]1. Date and time○ Date and time: 09:00-11:0...](https://img4.findhealthclinics.com/748/994/1043414917489940.jpg)
![[MD] 제22회 의료기기 혁신 세미나 (7.3 수 오후2시, 베스티안병원& 온라인(줌) 주제 :"의료기기 홍보&매출 전략■ (재)베스티안재단은 2018년도 오송에 베스티안메디클러스터를 설립하고 병원을 운영중입니다....](https://img5.findhealthclinics.com/776/773/1007303687767730.jpg)
![[협약체결] 국가첨단전략산업특화단지 업무협약 우리병원은 7일 오송 C&V센터에서 산업부에서 공모중인 바이오 분야 국가첨단전략산업 특화단지 지원을 위한 업무협약을 충청북도, 청주시, 오송첨단의료산업진흥재단, 재생의료진...](https://img4.findhealthclinics.com/582/668/926714185826681.jpg)
![[1/17] 보건 의료계 주요 뉴스 베스티안 클리핑(by HG MIN)[1. 의료계 주요 이슈] 의대 정원 복지부 "의대 증원 몇명 적정" vs 의협 "회신 거부“https://www.dailymedi.com/ne...](https://img5.findhealthclinics.com/047/156/913598690471564.jpg)